Impax Asset Management Group’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-4,116	Closed	-$1.35M	–	327
2024 Q4	$1.35M	Buy	4,116 +1,049	+34%	+$330K	0.01%	258
2024 Q3	$921K	Buy	3,067 +1,102	+56%	+$337K	﹤0.01%	287
2024 Q2	$647K	Hold	1,965	–	–	﹤0.01%	302
2024 Q1	$778K	Hold	1,965	–	–	﹤0.01%	290
2023 Q4	$692K	Buy	1,965 +800	+69%	+$283K	﹤0.01%	318
2023 Q3	$437K	Sell	1,165 -21	-2%	-$8.12K	﹤0.01%	351
2023 Q2	$454K	Hold	1,186	–	–	﹤0.01%	349
2023 Q1	$411K	Sell	1,186 -10,723	-90%	-$3.13M	﹤0.01%	359
2022 Q4	$2.8M	Sell	11,909 -468	-4%	-$111K	0.01%	212
2022 Q3	$3.05M	Buy	12,377 +1,688	+16%	+$514K	0.02%	211
2022 Q2	$3.23M	Hold	10,689	–	–	0.02%	210
2022 Q1	$4.39M	Sell	10,689 -55	-0.5%	-$21.5K	0.02%	202
2021 Q4	$5.04M	Sell	10,744 -293	-3%	-$126K	0.02%	196
2021 Q3	$4.69M	Buy	11,037 +6,600	+149%	+$2.78M	0.02%	204
2021 Q2	$1.59M	Hold	4,437	–	–	0.01%	259
2021 Q1	$1.25M	Buy	+4,437	New	+$1.27M	0.01%	270